Development and Validation of a Quantitative NMR Method for the Determination of the Commercial Tablet Formulation of Sulfasalazine

被引:4
|
作者
Su, Feng [1 ,2 ]
Sun, Zi-qing [1 ,2 ]
Liang, Xian-Rui [1 ,2 ]
机构
[1] Zhejiang Univ Technol, Coll Pharmaceut Sci, Minist Educ, Key Lab Green Pharmaceut Technol & Related Equipm, Hangzhou 310014, Zhejiang, Peoples R China
[2] Zhejiang Univ Technol, Collaborat Innovat Ctr Yangtze River Delta Reg Gr, Natl Engn Res Ctr Proc Dev Act Pharmaceut Ingredi, Hangzhou 310014, Zhejiang, Peoples R China
基金
中国国家自然科学基金;
关键词
NMR; qNMR; sulfasalazine; method validation; commercial tablet formulation; pharmaceutical analysis; SPECTROSCOPY; SPECTROMETRY; H-1;
D O I
10.2174/1573412913666170707113548
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Introduction: Quantitative NMR spectroscopy (qNMR) is a rapid, simple and efficient method for the assay of sulfasalazine (SSZ) in commercial tablet formulation. Materials and Methods: The qNMR method was demonstrated using maleic acid as an internal standard and DMSO-d(6) as a solvent. The characteristic signals of SSZ at delta 8.36 ppm and maleic acid at delta 6.28 ppm were quantified. The reliability of the quantification method had been implemented successfully in validated experiments including specificity and selectivity, linearity, recovery, precision concentration rang, limit of detection (LOD), limit of quantification (LOQ), stability and robustness. Conclusion: The method was found to be liner (R-2 = 0.9991) from 8.62 to 20.14 mg/0.6 mL DMSO-d(6) in the drug concentration range. The maximum relative standard deviation (RSD) of recovery and precision were tested to be 0.59% and 0.65%, respectively. The LOD and LOQ were determined to be 0.02, 0.07 mg/mL, respectively. The RSD of stability was 0.05%. The robustness was demonstrated by changing four different parameters with the maximum difference less than 0.9%. In addition, the result of qNMR showed in good agreement with the HPLC and UV methods. Based on the experiments, the developed method was successfully applied to the determination of SSZ in commercial tablet.
引用
收藏
页码:39 / 44
页数:6
相关论文
共 50 条
  • [1] Development and Validation of an HPLC Method for the Determination of Lobeglitazone in Bulk and in Tablet Formulation
    Sai, Kalepu Eswar Krishna
    Srinivas, Medidi
    Kumari, Bula Udaya
    Sumalatha, Chepyala
    Madhavi, Arram
    INTERNATIONAL JOURNAL OF PHARMACEUTICAL INVESTIGATION, 2024, 14 (01) : 204 - 211
  • [2] Quantitative determination and validation of topiramate and its tablet formulation by 1H-NMR spectroscopy
    Qin, Lingping
    Wang, Xinxian
    Lu, Dingqiang
    ANALYTICAL METHODS, 2019, 11 (05) : 661 - 668
  • [3] Development and validation of a HPLC method for the determination of buprenorphine hydrochloride, naloxone hydrochloride and noroxymorphone in a tablet formulation
    Mostafavi, Ali
    Abedi, Ghazaleh
    Jamshidi, Ahmad
    Afzali, Daryoush
    Talebi, Mohammad
    TALANTA, 2009, 77 (04) : 1415 - 1419
  • [4] Development and Validation of UV Spectrophotometric Method for Determination of Trimetazidine Dihydrochloride in Modified Release Tablet Formulation
    K. Chomaničová
    Š. Husár
    K. Maráková
    M. Sýkorová
    Pharmaceutical Chemistry Journal, 2022, 56 : 570 - 575
  • [5] Development and Validation of UV Spectrophotometric Method for Determination of Trimetazidine Dihydrochloride in Modified Release Tablet Formulation
    Chomanicova, K.
    Husar, S.
    Marakova, K.
    Sykorova, M.
    PHARMACEUTICAL CHEMISTRY JOURNAL, 2022, 56 (04) : 570 - 575
  • [6] Method Development and Validation for Determination of Voglibose in Tablet Formulation Using LC-MS/MS
    Rajput, Mithlesh
    Dahiya, Meenakshi
    Kumari, Premlata
    Kalra, Kamini
    Aggarwal, Manjeet
    Khandal, R. K.
    E-JOURNAL OF CHEMISTRY, 2011, 8 (04) : 1770 - 1783
  • [7] DEVELOPMENT AND VALIDATION OF A HPLC-UV METHOD FOR SIMULTANEOUS DETERMINATION OF CEFIXIME AND OFLOXACIN IN TABLET FORMULATION
    Kundu, Sarbojit
    Majumder, Tapas
    Barat, Prasanta Kumar
    Ray, Subrata Kumar
    INTERNATIONAL JOURNAL OF PHARMACEUTICAL SCIENCES AND RESEARCH, 2015, 6 (02): : 884 - 889
  • [8] Development and validation of a stability indicating UPLC method for determination of ticlopidine hydrochloride in its tablet formulation
    Ram, Vijay
    Kher, Govind
    Dubal, Kapil
    Dodiya, Bhavesh
    Joshi, Hitendra
    SAUDI PHARMACEUTICAL JOURNAL, 2011, 19 (03) : 159 - 164
  • [9] Development and Validation of a Stability Indicating HPLC Assay Method for Determination of Warfarin Sodium in Tablet Formulation
    Ram, Vijay R.
    Dubal, Kapil L.
    Dave, Pragnesh N.
    Joshi, Hitendra S.
    CHEMICAL METHODOLOGIES, 2019, 3 (03): : 328 - 345
  • [10] Development and validation of a gradient HPLC method for the determination of clindamycin and related compounds in a novel tablet formulation
    Platzer, DJ
    White, BA
    JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2006, 41 (01) : 84 - 88